Insights into the structure and 3D spatial arrangement of the b-ketoacyl carrier protein synthases by Vlachakis, Dimitrios et al.
The b-ketoacyl carrier protein synthases (the KAS en-
zymes) are key enzymes that can be used as potential 
anti-Plasmodium drug targets. In bacteria, three KAS 
enzymes have been identified (KAS I, KAS II and 
KAS III), whilst in Plasmodium a KAS I/II and KAS 
III enzyme has been reported. The protein has a total 
of four active sites, which have been found to be dif-
ferent to each other, rather than four copies of the same 
active site. The active sites differ not only in the type 
of interaction they establish with the ligand, but, in the 
case of Cerulenin as a ligand, the active sites of the 
KAS I/II enzyme also differ in the number of residues 
involved in the ligand protein interaction. This is very 
interesting biochemically, because these differences 
imply that the affinity of each active site for binding to 
the ligand might be different as well. 
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Introduction 
 
Malaria is a parasitic disease transmitted by mosqui-
toes that can be lethal if left untreated (Figure 1). The 
real cause of malaria, a single-cell parasite called plas-
modium, was discovered in the end of the 19th century 
(Komaki-Yasude et al. 2013). The parasite can be 
transmitted from an infected person to another through 
the bite of a female Anopheles mosquito (Olupot-
Olupot et al. 20183).  Today, there is an urgent need 
for new drugs since most known antimalarial drugs are 
rapidly losing their effectiveness, as the rate of drug 
resistance increases. P. falciparum is a member of the 
protistan phylum Apicomplexa (mostly parasites, the 
Apicomplexa are named after a characteristic apical 
complex of microtubules within the cell). A curious 
feature of the apicomplexan parasites is that these sin-
gle cell organisms harbour a plastid; otherwise better 
known as an organelle found in plants and algae and 
classified into leucoplasts, chromoplasts and chloro-
plasts (Menard et al. 2013). This association, which is 
symbiotic today, is thought to have arisen via the en-
gulfment of a cyanobacterium-like prokaryotic cell by 
an ancestor of the parasite (McFadden & Roos 1998). 
 The b-ketoacyl carrier protein synthases (b-
KAS) are key regulators of fatty acid biosynthesis 
(Klein et al. 2013), which has emerged as a target for 
the development of therapeutic agents (Komaki-
Yasude et al. 2013). Thiolactomycin and cerulenin are 
two natural ligands, capable of binding to the active 
site of b-KAS enzymes and inhibit their function 
(Komaki-Yasude et al. 2013). A variety of different 
structures of these enzymes,  from different origins, 
have already been determined from X-Ray and NMR 
studies. An extensively studied source of proteins is 
the E. coli bacterium. The latter is a type of bacterium 
commonly found in the intestine of animals and hu-
mans. E. coli, the whipping boy of microbiology and 
genetics labs around the world, is the most encoun-
tered bacterium in the clinical laboratory. As part of 
the normal flora of the human intestinal tract, E. coli 
plays a crucial role in food digestion by producing vi-
tamin K from undigested material in the large intes-
tine. It is a very versatile bacterium, being a very 
strong strain in terms of survival, requiring only basic 
nutrients and replicating very fast. As a result, a lot of 
research has been done on it including X-ray and NMR 
studies of its KAS proteins. 
 There are two main fatty acid synthesis sys-
tems (Komaki-Yasude et al. 2013). The type I system, 
also known as the associated system, is found in the 
most complex organisms, such as mammals. This sys-
tem composes a unique and multifunctional polypep-
tide. The other, the type II or dissociated system, is 
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found in lower organisms such as bacteria and plants. 
This involves the cooperation and coordination of a 
variety of different enzymes, each having a unique task 
in the elongation of the fatty acid chain.  
 Three different synthases have been found to 
regulate the pathways of the type II system (KAS I, II 
and III). According to work done by Zhang et al. 
(2000), the KAS enzymes are mainly known for cata-
lysing the Claisen condensation reaction. This is done 
by the transport of an acyl primer to malonyl-ACP. 
The result is therefore a β-Ketoacyl-Acyl carrier pro-
tein elongated by two carbon units (Figure 1). 
 The β-Ketoacyl-Acyl Carrier Protein Synthase 
I (KAS I) plays a very important role in the elongation 
of fatty acids. Studies have shown that mutants lacking 
the KAS I enzyme face serious problems in growth 
and require exogenous unsaturated fatty acids. The 
function of KAS II is to mainly control the temperature
- dependent regulation of fatty acid composition. Lack 
of KAS II will result in failure of the elongation of 
palmitoleate to cis-vaccenate. However, under stan-
dard culture conditions, growth is not suppressed 
(Komaki-Yasude et al. 2013). Finally, KAS III is re-
sponsible for controlling the rate of fatty acid synthe-
sis,  by catalyzing the first step in the pathway. 
 The β-ketoacyl synthase (KAS) components of 
fatty acids, together with polyketide synthase, create 
new carbon-carbon bonds by carrying out Claisen con-
densations. There are three main steps in these reac-
tions that result in the elongation of specific primers. 
The first part involves the transfer of an acyl primer 
substrate from the acyl carrier protein (ACP) or CoA 
to a cysteine residue of the condensing enzyme. The  
second part consists of decarboxylation of an ACP-
bound elongating substrate, so as to give a carbanion 
and, the last part, is the condensation of the carbanion 
with the carbonyl carbon of the enzyme-bound acyl 
primer. Three KAS isoenzymes participate in the syn-
thesis of fatty acid carbon skeletons in plant plastids 
and E. coli, as part of multifunctional fatty acid syn-
thase complexes, in which each protein is encoded by 
a discrete gene. Substrate specificities of KAS I, II and 
III overlap. KAS III is specialized in the first elonga-
tion step from C2 to C4 and uses a CoA-activated 
primer substrate. KAS I and II employ ACP-activated 
primer substrates. In plastids, KAS I extends C4 to C16 
whereupon KAS II carries out an additional step to 
give C18. KAS proteins with 85% identity to KAS II, 
called KAS IV, found in the seeds of some plants, are 
implicated in the synthesis of intermediate chain 
lengths from C8 to C14. Classic studies in E. coli sug-
gest that KAS I is unique in carrying out the first step 
of the unsaturated pathway whereas KAS II is unique 
in accomplishing the last one. In both plant plastids 
and E. coli, KAS I and II sequences show extensive 
homology, whereas KAS III sequences are more 
closely related to those of the polyketide chalcone syn-
thase (CHS) enzymes. Disparities in substrate specific-
ity are also reflected in differing sensitivities to antibi-
otics; for example, with cerulenin, which binds cova-
lently to the active-site cysteine, KAS III is insensitive, 
KAS I is highly sensitive and KAS II is moderately 
sensitive. Inhibitors of the β-KAS I of E. coli, include 
thiolactomycin and the natural drug cerulenin (Figure 
2). 
 The structure of b-ketoacyl carrier protein syn-
thases is a dimeric structure with each of the mono-
mers made up of a duplicated helix-sheet-helix motif 
(Figure 3). Cerulenin is an irreversible inhibitor of the 
b-ketoacyl carrier synthase proteins I and II. It estab-
lishes a covalent bond with the cysteine of the active 
site of the protein. It is not selectively antibacterial, as 
it has been found that it is a possible inhibitor of the 
condensation reaction, which is catalyzed by the multi-
functional fatty acid synthase type I, that is found in 
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Figure 1. The Claisen reaction between acetyl-CoA and 
malonyl-CoA illustrates how b-keto esters are built up by 
nature using the enolate derived from acetyl-CoA as nucleo-
phile. This reaction plays an important role in the biosynthe-
sis of fatty acids.  
Figure 2. The structures of thiolactomycin (A) and cerulenin (B). 
A B 
mammals (Sato et al. 2005, Sharma et al. 2007). It has 
also been found that Cerulenin has anti-neoplastic ac-
tivities, from experiments in mice. Thiolactomycin, on 
the other hand, is a molecule that can reversibly inhibit 
type II fatty acid synthases, even though it is not active 
against type I (Ramya et al. 2007, Roberts et al. 2003). 
Thiolactomycin shows activity against Gram-negative 
anaerobes, from the periodontal disease, and from its 
ability to inhibit mycolic acid. It  is also an antimyco-
bacterial agent. Finally, this drug can be used as an 
agent against malaria and trypanosomes, which makes 
it an ideal antimicrobial research tool. 
 
Results & Discussion 
 
The Ligand-Protein Contacts (LPC) analysis was per-
formed on both 1FJ4 and 1FJ8, both of which corre-
spond to the KAS I protein, with thiolactomycin and 
cerulenin docked, respectively (Vlachakis et al. 2009). 
The active sites were studied in terms of their distance 
from the ligand, their exposed contact accessible area 
and the type of bond that they establish (Palaiomylitou 
et al. 2008). Four groups of interaction types were gen-
erated by the LPC analysis: hydrophilic-hydrophilic 
(hydrogen bond), aromatic-aromatic, hydrophobic-
hydrophobic and hydrophobic-hydrophilic contact 
(Vangelatos et al. 2009). 
 As shown in Table 1, the most variable inter-
action type among the subunits is the hydrophobic-
hydrophilic contact. Those bonds are not as strong as 
the h-bonds but are still very important in defining the 
affinity of the ligand's binding to the active site of the 
protein. Hydrophobic interactions are the major driv-
ing force between non-polar groups and water that 
force the non-polar groups to aggregate together in 
order to minimise their surface area and contact with 
the latter. It should be noted that hydrophobic/
hydrophilic interactions belong to the dominant forces 
determining protein structure (Sellis et al. 2009). On 
the other hand, hydrogen bonds are intermolecular 
forces between strongly charged dipoles located on 
different molecules or different parts of a single large 
molecule. Although stronger than most other intermo-
lecular forces, hydrogen bonds are much weaker than 
both ionic and covalent bonds. The hydrogen bond has 
only ~5% the strength of a covalent bond. However, 
when many hydrogen bonds are formed between two 
molecules (or parts of the same molecule), the result-
ing union can be sufficiently strong so as to be quite 
stable. 
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Figure 3. The structure of β-ketoacyl-[acyl-carrier-protein] synthase I, coloured in CPK (A), by chain (B), by chain in cartoon 
display with the protein’s motifs visible (C) and by motif in cartoon mode (D). A-helices are in pink colour and β-sheets are in 
orange. 
 
 
153   Journal of Molecular Biochemistry, 2013 
Table 1. LPC analysis on the characteristics and the interactions that take place between the KAS I protein and thiolactomycin 
(pdb entry: 1FJ4) or Cerulenin (pdb entry: 1FJ8). 
Thiolactomycin 
Residue Dist Surf HB Arom Phob DC 
163 CYS 
206 ALA 
229 PHE 
265 ASP 
268 ASP 
270 VAL 
271 ALA 
272 PRO 
298 HIS 
300 THR 
302 THR 
305 GLY 
333 HIS 
390 PHE 
391 GLY 
392 PHE 
393 GLY 
394 GLY 
396 ASN 
3.2 
5.5 
3.4 
5.2 
3.8 
3.5 
3.3 
3.9 
2.8 
3.7 
4.0 
4.0 
2.6 
3.3 
3.5 
3.7 
3.8 
3.3 
5.0 
3.2 
5.6 
3.4 
5.2 
3.8 
3.4 
3.2 
3.9 
2.9 
3.7 
3.9 
3.9 
2.7 
3.3 
3.6 
3.8 
3.8 
3.4 
5.0 
3.2 
5.4 
3.5 
5.1 
3.7 
3.5 
3.2 
3.8 
3.0 
3.8 
4.0 
4.0 
2.7 
3.3 
3.6 
3.6 
3.9 
3.3 
5.0 
3.3 
5.6 
3.5 
4.4 
3.7 
3.6 
3.3 
3.8 
2.9 
3.7 
3.9 
4.0 
2.7 
3.2 
3.5 
3.9 
3.9 
3.3 
4.8 
13.0 
1.8 
40.2 
0.4 
5.2 
13.0 
41.3 
30.3 
21.7 
20.9 
14.4 
27.0 
31.2 
46.4 
18.8 
30.1 
4.5 
35.2 
5.6 
12.4 
1.8 
39.7 
0.2 
6.1 
12.8 
42.2 
30.3 
23.6 
20.0 
16.6 
26.6 
30.6 
44.4 
19.3 
29.7 
5.4 
33.0 
5.6 
13.0 
2.0 
39.7 
0.4 
6.7 
13.7 
41.3 
40.1 
21.6 
19.3 
14.9 
17.3 
30.9 
43.5 
19.1 
31.0 
3.8 
34.1 
5.6 
12.5 
1.8 
37.9 
0.9 
5.2 
12.3 
42.6 
40.0 
23.0 
20.6 
16.6 
17.4 
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Cerulenin 
Residue Dist Surf HB Arom Phob DC 
106  GLY 
107  GLY 
110  PRO 
162  ALA 
163  CYS 
191  GLU 
197  MET 
200  GLU 
201  PHE 
229  PHE 
298  HIS 
300  THR 
333  HIS 
335  LEU 
390  PHE 
391  GLY 
392  PHE 
113  GLN 
133  VAL 
134  VAL 
137  ALA 
138  MET 
3.2 
3.5 
4.3 
3.3 
1.9 
4.7 
3.4 
2.8 
3.0 
5.0 
3.0 
4.0 
2.8 
4.2 
3.7 
2.9 
2.7 
3.5 
X 
3.3 
3.3 
3.4 
3.4 
3.7 
4.5 
3.3 
1.9 
4.8 
3.4 
2.7 
2.9 
5.0 
2.7 
4.0 
2.8 
4.2 
3.6 
2.8 
2.7 
3.3 
4.6 
3.5 
3.4 
3.6 
3.1 
3.6 
4.3 
3.3 
1.9 
4.9 
3.3 
2.9 
2.7 
4.8 
2.8 
3.8 
2.6 
4.3 
3.8 
2.9 
2.7 
2.9 
X 
3.4 
3.3 
3.4 
3.3 
3.6 
4.4 
3.3 
1.9 
4.8 
3.4 
2.8 
2.8 
4.9 
2.8 
3.9 
2.7 
4.2 
3.7 
2.8 
2.7 
4.3 
X 
3.5 
3.4 
3.6 
29.2 
9.0 
9.2 
17.9 
65.1 
0.9 
31.6 
30.3 
45.3 
7.2 
18.3 
2.9 
25.7 
18.2 
7.4 
15.8 
72.8 
19.3 
X 
18.1 
27.6 
34.8 
28.5 
7.6 
7.9 
17.3 
61.4 
0.2 
30.1 
30.3 
44.8 
7.0 
28.8 
2.9 
17.5 
17.3 
7.6 
16.8 
70.4 
27.1 
0.7 
25.0 
16.6 
34.3 
31.9 
7.2 
7.6 
15.9 
58.4 
0.2 
33.2 
28.9 
49.8 
7.7 
20.4 
3.8 
29.4 
17.9 
5.9 
10.1 
67.6 
34.5 
X 
19.2 
11.7 
35.7 
30.1 
7.6 
7.6 
16.6 
58.6 
0.7 
38.8 
34.5 
49.9 
6.3 
20.2 
3.4 
28.5 
17.9 
6.7 
15.1 
70.3 
11.0 
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Legend 
Colors:  Red = subunit A, Green = subunit B, Blue = subunit C, Gray = subunit D. 
  Brown = subunit A, Light Blue = subunit B, Purple = subunit C, Orange = subunit D. 
Dist:  nearest distance (Å) between atoms of the ligand and the residue 
Surf:  contact surface area (Å2) between the ligand and the residue 
HB:  hydrophilic-hydrophilic contact (hydrogen bond) 
Arom:  aromatic-aromatic contact 
Phob:  hydrophobic-hydrophobic contact 
DC:  hydrophobic-hydrophilic contact (destabilizing contact) 
+/-:  indicates presence/absence of a specific contacts 
Underlined: indicates residues contacting ligand by their side chain (including CA atoms) 
 The differences in the interaction between the 
four subunits of the KAS enzyme when thiolactomycin 
and cerulenin bind are shown in Figure 4. In the case 
of thiolactomycin, there are only differences in the hy-
drophobic-hydrophilic contacts between the protein 
and the ligand. Because those differences though are 
not many and aren’t particularly strong, one could 
even ignore them; even though, as it has already been 
mentioned, the hydrophobic-hydrophilic contacts are 
key contacts, which determine the protein structure. 
 On the other hand, when cerulenin binds to the 
KAS enzyme, there are more significant differences 
among the four subunits of the protein. More specifi-
cally, subunits A and B both establish a hydrogen bond 
between the residue Cys163 and the ligand, whereas 
subunits C and D don't. All the other interactions be-
tween the ligand and the active site of the protein are 
exactly the same, as far as Cys163 is concerned. An-
other case with varying hydrogen bond interactions is 
Thr300. This residue establishes a hydrogen bond with 
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Figure 4. Interactions of the KAS I enzyme. The interactions that thiolactomycin (A) and cerulenin (B) establish with the ac-
tive site of the KAS I enzyme (data from LPC analysis of the 1FJ4 and 1FJ8 pdb files, respectively). Note that cerulenin only 
interacts with Val134 (in bold) in subunit B.   
  A 
B 
the ligand only in subunit C. The greatest difference 
among the active sites of the four subunits is the 
Val133 residue, which is only found in the B subunit. 
The existence of Val133 in the active site of the B sub-
unit has an effect on the properties of this particular 
site as it establishes a DC interaction with the ligand. 
Another difference between the active sites involves 
the non-establishment of DC bonds between the ligand 
and Gln113 in subunit D, the establishment of a DC 
bond between the ligand and Met138 in subunit C, the 
establishment of a DC bond between the ligand and 
Ala137 in subunit D and finally, the establishment of a 
DC bond between cerulenin and Met197, only in the B 
and D subunits of the protein. 
 The active site of 1FJ4, which was isolated 
using the LPC analysis software, is depicted in Figure 
4. 1FJ4 is a complex of the KAS protein with thiolac-
tomycin. The pdb file was edited and only Subunit A 
was retained. Then, based on the results of the LPC 
analysis, only the residues of the active site and the 
ligand were retained. Following the same procedures 
155   Journal of Molecular Biochemistry, 2013   
Figure 5. The active site of the KAS I enzyme. 
Residues Surface (Å2) Distance (Å) 
Phe390 46.4 1.09 
Phe392 30.1 1.21 
His298 21.7 1.68 
Ala206 1.8 0.13 
Asp265 0.4 0.21 
Table 2. Contact surface area (Å2) and movement distance 
(Å) of some residues in the KAS I protein’s active site.  
the active site of KAS I without any ligand docked was 
also isolated (pdb entry: 1G5X). 
 Figures 5A and 5B show the active site of the 
KAS I enzyme, with and without the ligand docked, 
respectively (in 5A thiolactomycin is in yellow). In 
Figures 5C and 5D, the two active sites have been su-
perimposed. In Figure 5C the active site without the 
ligand is in blue and in 5D in red. It is obvious that the 
conformation of the active site changes significantly 
with the ligand binding. The RMSd value of the two 
active site superimposition was found to be 0.67 A, 
with 19 residues of each one of the two active sites 
involved in the calculation. Movement of the residues 
in the active site when the ligand binds can also be 
seen in Figures 5E and 5F, were the labels of the resi-
dues have been added as well. 
 From the LPC analysis it was found that the 
contact surface area (calculated in Å2) between the 
ligand and the residue is directly proportional to the 
degree of the residue’s movement when the ligand 
binds to the active site. In Table 2 the contact surface 
area (Å2) and the movement distance (Å) of some resi-
dues have been summarized.  
 The LPC analysis revealed a several differ-
ences between the four active sites of the KAS I en-
zyme with cerulenin bound to it. In order to investigate 
the conformational differences between the four sub-
units of the KAS I protein (with cerulenin in the active 
site), they were superimposed. Figure 6α shows the 
four superimposed subunits together with a subunit-
colour reference below. Then in 6β, a part of the super-
imposition near the outer area of the four subunits is 
magnified, whereas 6γ focuses on the superimposed 
area around the active sites of the subunits. It is very 
clear that the superimposition in the active-site area of 
the subunits has been done smoothly, as there are no 
big movements and conformational changes. On the 
other hand, a lot differences between the four subunits 
can be observed on the outside of the protein. In Figure 
6δ, a part of 6β has been further magnified and the dis-
tances between the same residues on different subunits 
have been measured. These are huge differences as 
they can be as large as 5.76 A. One could dismiss these 
Journal of Molecular Biochemistry, 2013   156 
Figure 6. Different views of the superimposition of the four subunits of the KAS I enzyme with cerulenin docked (pdb entry: 
1FJ8).  
 
differences as insignificant to the function of the pro-
tein, as they are far away from the active site. How-
ever, according to the work by Olsen et al. (2001) it 
has been found that there is a path the ligand has to 
follow to reach the active site of the KAS I protein. As 
a result, the conformation of the outside of the protein 
might have an effect on the easiness or difficulty that 
the ligand will have to cope with, in order to reach the 
active site. Thus, the conformation on the outside of 
the subunit could affect its affinity for binding the 
ligand as a whole. Figure 7 shows part of the work 
done by Olsen et al. (2001) emphasising the entrance 
of the active site of the KAS I subunit. It is assumed 
that conformational changes between KAS I and KAS 
II proteins are responsible for ligand selectivity and 
binding affinity. 
 
Conclusions 
 
The KAS protein consists of four identical subunits 
with an active site on each one. It was found that the 
way the ligand binds is different among the four active 
sites of the protein. Thiolactomycin binds by establish-
ing different sets of interactions among the active sites 
of the protein. The residues of the active site though 
are the same in all four active sites of the protein. On 
the other hand, cerulenin not only binds by establish-
ing different interactions among the active sites, but it 
also uses one more residue in subunit B. As a result, it 
is not only the type of interactions that varies from ac-
tive site to active site, but it is also the number of resi-
dues too. Moreover, superimpositions of the empty 
active site over the same active site with the ligand 
present, reveal significant active-site residue move-
ment when the ligand binds. This occurs for both thio-
lactomycin and cerulenin. It was found that the dis-
tance that the active site’s residues move when the 
ligand binds, depends on the exposed contact surface 
of each residue. Residues with a large contact surface 
area moved a lot, whereas residues with little exposed 
contact surface area either moved little or not at all. 
The key residues are the ones that make up the active 
site of the protein (especially the two histidines, which 
establish H-bonds) and those that are generally con-
served (evolutionary). This preliminary work will pave 
the way towards a holistic future docking, de novo 
drug-design and lead optimization of potent anti-
plasmodium agents. 
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